私たちに関しては

あらゆる場面でインスピレーションを見つける

パキスタンは、心臓発作、心不全、その他の心臓病に対して非常に不安定なシナリオを提示しています。これらは、我が国の主要な死因であるためです。パキスタンでは、心臓病のために1時間ごとに46人が亡くなっています。心臓血管装置およびインプラントに対する国内需要はますます高まっていますが、パキスタンは輸入された心臓装置に完全に依存しています。法外な費用がかかるため、輸入されたデバイスは、罹患した人口の20％しかアクセスできず、残りの80％は、健康と平均余命を改善できる治療を受けられません。

首相官邸とパキスタン最高裁判所の特別な指示の下、国立科学技術大学（NUST）、イスラマバードに設立されたN-ovative Health Technologies（NHT）Pvt Ltdは、当面の需要を満たすヘルスケアソリューションの作成に取り組んでいます。毎年85億ルピーに上る貴重な外国為替の節約、心臓ステントとカテーテルの毎年の輸入、および輸出による外国為替の生成に特に重点を置いています。

NHTは、ヘルスケア技術の研究開発や、ベアメタルステント、薬剤溶出ステント、血管形成バルーンカテーテルなどの救命医療機器やインプラントの大量生産に積極的に取り組んでいる最先端の医療機器製造施設です。、診断用血管造影カテーテル、人工呼吸器など、輸入バージョンの数分の1の価格で利用できるようになります。

科学技術省（MoST）が後援し、費用効果の高い高品質の医療機器を自国で製造することを任務として、この施設はパキスタン証券取引委員会（SECP）の公共部門企業として設立されました。 NHTは、欧州委員会の通知機関からISO 13485：2016の認証を受けており、パキスタンの薬物規制当局（DRAP）によって承認されています。

CEO'S MESSAGE

“Don’t limit yourself. Many people limit themselves to what they think they can do. You can go as far as your mind lets you. What you believe, remember, you can achieve.”

Dr Kamran Akhtar

CEO NHTPL

Core Values

Innovation
Quality
Teamwork
Empathy
Integrity
Social Responsibility

Vision

To set national and regional trends of technology innovation and self-sufficiency by indigenous production of medical devices, redefining healthcare in Pakistan and bringing solutions within the reach of common man.

Mission

To indigenously develop high-quality medical devices for local and international markets, that provide customer satisfaction in safety, quality and affordability, while complying with applicable international standards and regulatory requirements

History of Department

In 2006 Dr. Murtaza Najabat Ali while working in UK University developed a low-cost stent and inform President of Pakistan about its significant potential benefits for the deprived segments of the society. In 2007 he joined NESCOM on invitation of Chairman (Dr. Samar Mubarakmand) and established a pilot production plant where the initial R&D was carried out and Bare Metal Stent (stainless steel) was developed in collaboration with AFIC. In 2009 Dr. Murtaza Najabat Ali left for UK because NESCOM did not intend to take the established pilot-scale facility to the next level (i.e., commercial scale production). In 2013 Dr. Murtaza returned from UK & joined NUST to establish Bio medical engineering dept. at SMME where extensive research on medical devices technology was initiated. In 2014 effort was initiated with NESCOM for the transfer of stent production technology at NUST. In 2015 MoST approved Rs. 33 Million PC-1 for the establishment of facility to manufacture Angioplastry Balloon (PTCA) Catheters at NUST In 2016, the entire stent production technology worth RS. 55 Million located in NESCOM was transferred to NUST through MoST.In 2017, P.M Office and Supreme Court of Pakistan took notice of implanting substandard stents in patients in Punjab and gave Rector NUST and Dr. Murtaza a mandate to submit a new PC-1 related to the development of purpose-built Medical Devices Development Center (MDDC) at NUST.

In 2017, a PC-1 of worth Rs. 331.12 Million was approved by MoST . In 2017, core production team obtained training from the industrial partner in Germany. In 2017, the entire Production Technology (production and testing machines) were procured from industrial partners in Germany. In 2019 all the prerequisites pertaining to the international and national certification/lisencing of both production facility and products were successfully completed. In 2020, a state-of-the-art stent manufacturing facility was established and PC-IV against Rs. 331.12M was submitted to MoST.

During the completion of PC-1 related to the establishment of MDDC Project, Federal Government gave the following directives:

Take this project to the regular side (i.e. regular Operational Budget should be provided) and a Special Purpose Vehicle (SPV) in the form of Public Sector Company mode should be established for the commercialization of the MDDC Products.
Upscaling of production capacity in future with the help of Private Sector Partnership.
After the successful completion of PC-1, SPV in the form of Public Sector Company Mode as per the directives of Federal Government (N-ovative Health Technologies- NHT) was incorporated in July 2020 with Security Exchange Commission of Pakistan (SECP)

On 16th October 2020, Prime Minister Imran Khan inaugurated the N-ovative Health Technology Facility at the National University of Science and Technology (NUST).